12. Cardiogenic shock and cardiac arrest

ECMO-CS for therapy of cardiogenic shock

ECMO-CS
Objective
to investigate whether immediate implementation of extra-corporeal membrane oxygenation (ECMO) as compared to conservative therapy for cardiogenic shock in more effective
Study
investigator-initiated, multicentre, randomised trial
Population
patients with rapidly deteriorating or severe cardiogenic shock
Endpoints
composite of any-death, resuscitated cardiac arrest or implementation other mechanical circulatory support at 30 days
Conclusion
adverse clinical outcomes did not improve with immediate ECMO compared to no immediate ECMO for patients with rapidly deteriorating or severe cardiogenic shock
Ostadal et al. Circulation 2023:147: 454-464
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved